Estrace and Abraxane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Estrace (estradiol) and Abraxane (paclitaxel). Common drug interactions include vomiting among females.

The phase IV clinical study analyzes what interactions people have when they take Estrace and Abraxane. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Estrace?

Estrace has active ingredients of estradiol. It is often used in hormone replacement therapy. eHealthMe is studying from 16,703 Estrace users. Check the latest studies of Estrace.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

On Jul, 20, 2026

18 people who take Estrace and Abraxane together, and have interactions are studied.

What are the common drug interactions of Estrace and Abraxane, by gender? *:

female:

Vomiting
Asthenia (weakness)
Cellulitis (infection under the skin)
Chest pain
Chills (felling of cold)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Cold sweat
Constipation
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Death

male:

n/a

What are the common drug interactions of Estrace and Abraxane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Haematuria (presence of blood in urine)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Diplopia (double vision)
Osteonecrosis (death of bone)
Skin toxicity (skin damage due to toxin/poison)
Abdominal hernia
Alopecia (absence of hair from areas of the body)
Anxiety
Asthenia (weakness)

40-49:

n/a

50-59:

n/a

60+:

Vomiting
Asthenia (weakness)
Infusion site swelling
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Syncope (loss of consciousness with an inability to maintain postural tone)
Injection site induration
Injection site swelling
Metastases to bone (cancer spreads to bone)
Metastases to liver (cancer spreads to liver)
Parkinson's disease

What are the existing conditions these people have? *

Breast Cancer: 10 people, 55.56%
Immunodeficiency Common Variable: 4 people, 22.22%
Vulvovaginal Dryness: 2 people, 11.11%
Nausea (feeling of having an urge to vomit): 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 11.11%
Hypokalemia (low potassium): 2 people, 11.11%
Breast Pain: 1 person, 5.56%
Constipation: 1 person, 5.56%
Insomnia (sleeplessness): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Estrace and Abraxane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously